Announcement • Jun 02
Shanghai Chlor-Alkali Chemical Co., Ltd., Annual General Meeting, Jun 23, 2026 Shanghai Chlor-Alkali Chemical Co., Ltd., Annual General Meeting, Jun 23, 2026, at 09:30 China Standard Time. Location: No. 560, Xujiahui Road, Shanghai China Reported Earnings • Apr 21
Full year 2025 earnings released: EPS: CN¥0.75 (vs CN¥0.68 in FY 2024) Full year 2025 results: EPS: CN¥0.75 (up from CN¥0.68 in FY 2024). Revenue: CN¥7.82b (down 4.4% from FY 2024). Net income: CN¥862.6m (up 9.6% from FY 2024). Profit margin: 11% (up from 9.6% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Announcement • Mar 30
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026 Valuation Update With 7 Day Price Move • Jan 23
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥14.86, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 49x in the Chemicals industry in China. Total returns to shareholders of 59% over the past three years. Announcement • Dec 26
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report Fiscal Year 2025 Results on Apr 21, 2026 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report fiscal year 2025 results on Apr 21, 2026 New Risk • Dec 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 8.0% per year over the past 5 years. High level of non-cash earnings (31% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.4% average weekly change). Valuation Update With 7 Day Price Move • Nov 10
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥13.11, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 44x in the Chemicals industry in China. Total returns to shareholders of 40% over the past three years. Reported Earnings • Oct 28
Third quarter 2025 earnings released: EPS: CN¥0.15 (vs CN¥0.21 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.15 (down from CN¥0.21 in 3Q 2024). Revenue: CN¥2.11b (flat on 3Q 2024). Net income: CN¥169.7m (down 30% from 3Q 2024). Profit margin: 8.0% (down from 11% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Announcement • Sep 30
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Reported Earnings • Aug 29
Second quarter 2025 earnings released: EPS: CN¥0.18 (vs CN¥0.13 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.18 (up from CN¥0.13 in 2Q 2024). Revenue: CN¥1.84b (up 1.4% from 2Q 2024). Net income: CN¥211.4m (up 37% from 2Q 2024). Profit margin: 12% (up from 8.5% in 2Q 2024). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Declared Dividend • Jul 21
Dividend increased to CN¥0.21 Dividend of CN¥0.21 is 5.0% higher than last year. Ex-date: 23rd July 2025 Payment date: 23rd July 2025 Dividend yield will be 2.0%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (30% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 29% per year over the past 7 years. However, payments have been volatile during that time. Earnings per share has grown by 3.7% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Announcement • Jun 30
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025 Announcement • Jun 09
Shanghai Chlor-Alkali Chemical Co., Ltd., Annual General Meeting, Jun 30, 2025 Shanghai Chlor-Alkali Chemical Co., Ltd., Annual General Meeting, Jun 30, 2025, at 09:00 China Standard Time. Location: No. 560, Xujiahui Road, Shanghai China New Risk • May 02
New major risk - Revenue and earnings growth Earnings have declined by 0.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 0.9% per year over the past 5 years. High level of non-cash earnings (21% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows. Reported Earnings • Apr 15
Full year 2024 earnings released: EPS: CN¥0.68 (vs CN¥0.66 in FY 2023) Full year 2024 results: EPS: CN¥0.68 (up from CN¥0.66 in FY 2023). Revenue: CN¥8.18b (up 14% from FY 2023). Net income: CN¥787.4m (up 3.5% from FY 2023). Profit margin: 9.6% (in line with FY 2023). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings. Announcement • Mar 28
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥11.98, the stock trades at a trailing P/E ratio of 15x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 7.8% over the past three years. Announcement • Dec 27
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report Fiscal Year 2024 Results on Apr 15, 2025 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report fiscal year 2024 results on Apr 15, 2025 Valuation Update With 7 Day Price Move • Dec 11
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥11.13, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 37x in the Chemicals industry in China. Total loss to shareholders of 1.6% over the past three years. Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.13 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.21 (up from CN¥0.13 in 3Q 2023). Revenue: CN¥2.12b (up 16% from 3Q 2023). Net income: CN¥240.7m (up 62% from 3Q 2023). Profit margin: 11% (up from 8.2% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Announcement • Sep 30
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to CN¥9.18, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 33% over the past three years. Reported Earnings • Aug 03
Second quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.094 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.13 (up from CN¥0.094 in 2Q 2023). Revenue: CN¥1.82b (flat on 2Q 2023). Net income: CN¥154.3m (up 42% from 2Q 2023). Profit margin: 8.5% (up from 6.0% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Declared Dividend • Jul 11
Dividend of CN¥0.20 announced Shareholders will receive a dividend of CN¥0.20. Ex-date: 16th July 2024 Payment date: 16th July 2024 Dividend yield will be 2.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (30% earnings payout ratio) but not covered by cash flows (360% cash payout ratio). The dividend has increased by an average of 45% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 67% to shift the payout ratio to a potentially unsustainable range, which is more than the 6.7% EPS decline seen over the last 5 years. Announcement • Jun 28
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report First Half, 2024 Results on Aug 03, 2024 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report first half, 2024 results on Aug 03, 2024 Announcement • May 25
Shanghai Chlor-Alkali Chemical Co., Ltd., Annual General Meeting, Jun 13, 2024 Shanghai Chlor-Alkali Chemical Co., Ltd., Annual General Meeting, Jun 13, 2024, at 09:30 China Standard Time. Location: 3F, No. 560, Xujiahui Road, Shanghai China Reported Earnings • May 01
First quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.16 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.18 (up from CN¥0.16 in 1Q 2023). Revenue: CN¥2.07b (up 26% from 1Q 2023). Net income: CN¥211.6m (up 12% from 1Q 2023). Profit margin: 10% (down from 11% in 1Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Reported Earnings • Apr 18
Full year 2023 earnings released: EPS: CN¥0.66 (vs CN¥1.19 in FY 2022) Full year 2023 results: EPS: CN¥0.66 (down from CN¥1.19 in FY 2022). Revenue: CN¥7.21b (up 13% from FY 2022). Net income: CN¥760.5m (down 45% from FY 2022). Profit margin: 11% (down from 22% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Announcement • Mar 29
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥7.36, the stock trades at a trailing P/E ratio of 12.6x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 11% over the past three years. Announcement • Dec 30
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 16, 2024 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report fiscal year 2023 results on Apr 16, 2024 Reported Earnings • Oct 29
Third quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.22 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.22 in 3Q 2022). Revenue: CN¥1.82b (up 39% from 3Q 2022). Net income: CN¥148.7m (down 41% from 3Q 2022). Profit margin: 8.2% (down from 19% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 7% per year. Reported Earnings • Aug 08
Second quarter 2023 earnings released: EPS: CN¥0.094 (vs CN¥0.35 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.094 (down from CN¥0.35 in 2Q 2022). Revenue: CN¥1.80b (up 6.7% from 2Q 2022). Net income: CN¥108.8m (down 73% from 2Q 2022). Profit margin: 6.0% (down from 24% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Announcement • Jun 28
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report First Half, 2023 Results on Aug 08, 2023 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report first half, 2023 results on Aug 08, 2023 Reported Earnings • Mar 21
Full year 2022 earnings released: EPS: CN¥1.19 (vs CN¥1.53 in FY 2021) Full year 2022 results: EPS: CN¥1.19 (down from CN¥1.53 in FY 2021). Revenue: CN¥6.36b (down 4.5% from FY 2021). Net income: CN¥1.37b (down 23% from FY 2021). Profit margin: 22% (down from 27% in FY 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Guiping Cao was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.22 (vs CN¥0.41 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.22 (down from CN¥0.41 in 3Q 2021). Revenue: CN¥1.31b (down 22% from 3Q 2021). Net income: CN¥253.3m (down 47% from 3Q 2021). Profit margin: 19% (down from 29% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 31
Second quarter 2022 earnings released: EPS: CN¥0.35 (vs CN¥0.28 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.35 (up from CN¥0.28 in 2Q 2021). Revenue: CN¥1.69b (up 17% from 2Q 2021). Net income: CN¥400.9m (up 25% from 2Q 2021). Profit margin: 24% (up from 22% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 30
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥13.31, the stock trades at a trailing P/E ratio of 8.1x. Average trailing P/E is 25x in the Chemicals industry in China. Total returns to shareholders of 76% over the past three years. Reported Earnings • May 02
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: EPS: CN¥0.42 (up from CN¥0.30 in 1Q 2021). Revenue: CN¥1.98b (up 28% from 1Q 2021). Net income: CN¥485.6m (up 41% from 1Q 2021). Profit margin: 25% (up from 22% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates by 29%. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. 4 independent directors (5 non-independent directors). Independent Director Zhengzhong Shao was the last independent director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥13.53, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 47% over the past three years. Reported Earnings • Mar 11
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: CN¥1.53 (up from CN¥0.53 in FY 2020). Revenue: CN¥6.66b (up 36% from FY 2020). Net income: CN¥1.77b (up 192% from FY 2020). Profit margin: 27% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates by 29%. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 12% per year. Reported Earnings • Oct 26
Third quarter 2021 earnings released: EPS CN¥0.41 (vs CN¥0.17 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥1.67b (up 29% from 3Q 2020). Net income: CN¥477.4m (up 149% from 3Q 2020). Profit margin: 29% (up from 15% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 31% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥16.12, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 127% over the past three years. Valuation Update With 7 Day Price Move • Sep 07
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥13.15, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 93% over the past three years. Reported Earnings • Aug 26
Second quarter 2021 earnings released: EPS CN¥0.28 (vs CN¥0.05 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.45b (up 45% from 2Q 2020). Net income: CN¥320.5m (up 449% from 2Q 2020). Profit margin: 22% (up from 5.8% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Reported Earnings • Apr 29
First quarter 2021 earnings released: EPS CN¥0.30 (vs CN¥0.076 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.55b (up 35% from 1Q 2020). Net income: CN¥345.6m (up 292% from 1Q 2020). Profit margin: 22% (up from 7.7% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Reported Earnings • Apr 10
Full year 2020 earnings released: EPS CN¥0.53 (vs CN¥0.70 in FY 2019) The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥4.89b (down 24% from FY 2019). Net income: CN¥606.7m (down 25% from FY 2019). Profit margin: 12% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 22
New 90-day high: CN¥8.67 The company is up 6.0% from its price of CN¥8.20 on 24 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. Valuation Update With 7 Day Price Move • Feb 22
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥8.67, the stock is trading at a trailing P/E ratio of 19.3x, up from the previous P/E ratio of 16.3x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 19%. Is New 90 Day High Low • Jan 11
New 90-day low: CN¥6.99 The company is down 8.0% from its price of CN¥7.57 on 13 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Announcement • Oct 27
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report Q3, 2020 Results on Oct 30, 2020 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report Q3, 2020 results on Oct 30, 2020 Announcement • Jul 10
Shanghai Chlor-Alkali Chemical Co., Ltd. to Report First Half, 2020 Results on Aug 27, 2020 Shanghai Chlor-Alkali Chemical Co., Ltd. announced that they will report first half, 2020 results on Aug 27, 2020 